Doi.org/10.1210/jc.2015-2725
Revision as of 06:10, 18 August 2022 by 187.21.138.9 (talk) (Created page with "== Target Article == The impact of chronic liraglutide therapy on glucagon secretion in type 2 diabetes: insight from the LIBRA trial; Kramer C.K., et al; The Journal of Clinical Endocrinology & Metabolism; 2015; https://doi.org/10.1210/jc.2015-2725 == Article providing comments == Letter to the Editor: Comment on “The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial” by Kramer C.K., et al; Kalra, Sanjay; Gu...")
Target Article[edit | edit source]
The impact of chronic liraglutide therapy on glucagon secretion in type 2 diabetes: insight from the LIBRA trial; Kramer C.K., et al; The Journal of Clinical Endocrinology & Metabolism; 2015; https://doi.org/10.1210/jc.2015-2725
Article providing comments[edit | edit source]
Letter to the Editor: Comment on “The Impact of Chronic Liraglutide Therapy on Glucagon Secretion in Type 2 Diabetes: Insight From the LIBRA Trial” by Kramer C.K., et al; Kalra, Sanjay; Gupta, Yashdeep; ; The Journal of Clinical Endocrinology & Metabolism; 2015-11-01 https://doi.org/10.1210/jc.2015-3494
Summary[edit | edit source]
Note: Opened to append information.